Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 45 out of 100. Disparities

Topic: Risk, prevention and care in population studies

Plain-language summary

Ethnoracial identity was significantly associated with the likelihood of ACP engagement. The association between ethnoracial identity and the number of ACP engagement was significant after adjusting for covariates. Non-Hispanic Black (Risk Ratio [RR] = 0.670, 95% Confidence Interval [CI] = [0.607, 0.740]) and Hispanic (RR= 0.597, 95% CI = [0.518, 0.688]) individuals with ADRD engaged in fewer ACP than non-Hispanic White counterparts. Factors such as gender, marital status, household wealth and income, number of ADL difficulty, number of health conditions, self-rated health, and nursing home residency were differentially associated with the number of ACP engagement among three ethnoracial groups. The prevalence of engagement in ACP varies across ethnoracial groups. Non-Hispanic Black and Hispanic individuals are less likely to engage in various aspects of ACP than their non-Hispanic white counterparts. Race/ethnicity-specific correlates of ACP should be considered to develop equitable strategies that promote ACP among diverse populations.

What this study adds

Evidence grade: Low

The record lists 5,420 participants. Non-Hispanic Black and Hispanic people with ADRD engaged in fewer advance care planning activities than non-Hispanic White counterparts. Reported effect size: RR= 0.597.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Amano, T., Inoue, M., Dixit, S., & Tarafder, A. J. (2025). Ethnoracial Disparities in Advance Care Planning Among People With Alzheimer’s Disease and Related Dementias. American Journal of Geriatric Psychiatry. https://doi.org/10.1016/j.jagp.2025.06.006

Vancouver

Amano T, Inoue M, Dixit S, Tarafder AJ. Ethnoracial Disparities in Advance Care Planning Among People With Alzheimer’s Disease and Related Dementias. American Journal of Geriatric Psychiatry. 2025. doi:10.1016/j.jagp.2025.06.006. PMID: 40628581.

BibTeX

@article{amano2025-40628581,
  author  = {Amano, Takashi and Inoue, Megumi and Dixit, Sharmilee and Tarafder, A J},
  title   = {{Ethnoracial Disparities in Advance Care Planning Among People With Alzheimer’s Disease and Related Dementias}},
  journal = {American Journal of Geriatric Psychiatry},
  year    = {2025},
  doi     = {10.1016/j.jagp.2025.06.006},
  pmid    = {40628581},
  url     = {https://doi.org/10.1016/j.jagp.2025.06.006}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

Non-Hispanic Black and Hispanic people with ADRD engaged in fewer advance care planning activities than non-Hispanic White counterparts. This is about care planning disparities, not about treating, curing, or preventing Alzheimer's disease.

Study details

How this study scored 45/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 1 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 43 of the 96 points it could be judged on, which is 45 of 100. Total 45 of 100.43 of the 96 points we could judge = 45 of 100

Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 43 of the 96 points we could judge it on, which is 45 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (American Journal of Geriatric Psychiatry)
Journal's citation record 2 / 4 American Journal of Geriatric Psychiatry: journal h-index 178 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 5,420 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 1 / 3 Rutgers, The State University of New Jersey: institution h-index 1,147 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40628581)
Free to read 2 / 2 Free to read
Points 43 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 43 of the 96 points we could judge it on is 45 out of 100.
Total 45 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Disparities from nearby years

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Disparities

See all studies in Disparities →